Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses
Tsewang Tashi(University of Utah), Josef T. Prchal(Huntsman Cancer Institute), Katherine Y. King(Baylor College of Medicine), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Kim Hickman(University of Utah), Sabina Świerczek(University of Utah), Soo Jin Kim, Nahla Heikal(University of Utah), Jihyun Song(University of Utah), Scott Litton(University of Utah)
Cited by 21
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441
NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
|Cancer Cell|2013|302
A common progenitor for human myeloid and lymphoid cells
|Nature|1978|277